What is Neurocrine Biosciences Inc's Market Cap?

Neurocrine Biosciences Inc's Market Cap is $15.8B, based on as-reported figures from SEC (XBRL) filings.

What is Neurocrine Biosciences Inc's Enterprise Value?

Neurocrine Biosciences Inc's Enterprise Value is $15.4B, based on as-reported figures from SEC (XBRL) filings.

What is Neurocrine Biosciences Inc's Trailing P/E?

Neurocrine Biosciences Inc's Trailing P/E is 22.4×, based on as-reported figures from SEC (XBRL) filings.

What is Neurocrine Biosciences Inc's Price / Sales?

Neurocrine Biosciences Inc's Price / Sales is 4.7×, based on as-reported figures from SEC (XBRL) filings.

What is Neurocrine Biosciences Inc's EV / Revenue?

Neurocrine Biosciences Inc's EV / Revenue is 4.6×, based on as-reported figures from SEC (XBRL) filings.

What is Neurocrine Biosciences Inc's EV / EBITDA?

Neurocrine Biosciences Inc's EV / EBITDA is 18.3×, based on as-reported figures from SEC (XBRL) filings.

What is Neurocrine Biosciences Inc's Revenue (TTM)?

Neurocrine Biosciences Inc's Revenue (TTM) is $3.4B, based on as-reported figures from SEC (XBRL) filings.

What is Neurocrine Biosciences Inc's Net Income (TTM)?

Neurocrine Biosciences Inc's Net Income (TTM) is $705.5M, based on as-reported figures from SEC (XBRL) filings.

What is Neurocrine Biosciences Inc's EBITDA?

Neurocrine Biosciences Inc's EBITDA is $842.1M, based on as-reported figures from SEC (XBRL) filings.

What is Neurocrine Biosciences Inc's Diluted EPS (TTM)?

Neurocrine Biosciences Inc's Diluted EPS (TTM) is 6.94, based on as-reported figures from SEC (XBRL) filings.

Neurocrine Biosciences Inc (NBIX) Financial Statements

Neurocrine Biosciences Inc

SIC 2836 · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

FIGI BBG001S8W4X9

XNAS · usd

155.14▲ 0.01 (0.01%)

As of 2026-09-09

Valuation

Market Cap

Enterprise Value

Trailing P/E

Price / Sales

EV / Revenue

EV / EBITDA

Financial Highlights

Revenue (TTM)

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin

Net Debt

Trading Information

Previous Close155.13

Day's Range152.38 – 155.55

52-Week Range122.10 – 186.12

Volume1.0M

Avg Volume1.3M

Share Statistics

Shares Outstanding

Employees2,000

ExchangeXNAS

Listed1996-05-23

Share count as of July 22, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Neurocrine Biosciences Inc (NBIX)

What is Neurocrine Biosciences Inc's Market Cap?: Neurocrine Biosciences Inc's Market Cap is $15.8B, based on as-reported figures from SEC (XBRL) filings.
What is Neurocrine Biosciences Inc's Enterprise Value?: Neurocrine Biosciences Inc's Enterprise Value is $15.4B, based on as-reported figures from SEC (XBRL) filings.
What is Neurocrine Biosciences Inc's Trailing P/E?: Neurocrine Biosciences Inc's Trailing P/E is 22.4×, based on as-reported figures from SEC (XBRL) filings.
What is Neurocrine Biosciences Inc's Price / Sales?: Neurocrine Biosciences Inc's Price / Sales is 4.7×, based on as-reported figures from SEC (XBRL) filings.
What is Neurocrine Biosciences Inc's EV / Revenue?: Neurocrine Biosciences Inc's EV / Revenue is 4.6×, based on as-reported figures from SEC (XBRL) filings.
What is Neurocrine Biosciences Inc's EV / EBITDA?: Neurocrine Biosciences Inc's EV / EBITDA is 18.3×, based on as-reported figures from SEC (XBRL) filings.
What is Neurocrine Biosciences Inc's Revenue (TTM)?: Neurocrine Biosciences Inc's Revenue (TTM) is $3.4B, based on as-reported figures from SEC (XBRL) filings.
What is Neurocrine Biosciences Inc's Net Income (TTM)?: Neurocrine Biosciences Inc's Net Income (TTM) is $705.5M, based on as-reported figures from SEC (XBRL) filings.
What is Neurocrine Biosciences Inc's EBITDA?: Neurocrine Biosciences Inc's EBITDA is $842.1M, based on as-reported figures from SEC (XBRL) filings.
What is Neurocrine Biosciences Inc's Diluted EPS (TTM)?: Neurocrine Biosciences Inc's Diluted EPS (TTM) is 6.94, based on as-reported figures from SEC (XBRL) filings.